Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically

American Journal of Surgical Pathology

Volumn 30, Issue 4, 2006, Pages 470-476

  Pitman, Sean D ^a   Huang, Qin ^c   Zuppan, Craig W ^a   Rowsell, Edward H ^a   Cao, Jeffrey D ^a   Berdeja, Jesus G ^b   Weiss, Lawrence M ^c   Wang, Jun ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Epstein Barr virus; Hodgkin lymphoma type; Hodgkin lymphoma like; Posttransplant lymphoproliferative disorder

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; LYMPHOPROLIFERATIVE DISEASE; MALE; MOLECULAR GENETICS; ORGAN TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PROGNOSIS; RECIPIENT; B LYMPHOCYTE; CELL CLONE; DIFFERENTIAL DIAGNOSIS; GENETICS; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; VIRUS INFECTION;

DNA; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; VIRUS RNA;

ADOLESCENT; ADULT; B-LYMPHOCYTES; CHILD; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; EPSTEIN-BARR VIRUS INFECTIONS; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HODGKIN DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; INFANT; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RNA, VIRAL;

EID: 33645919119     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200604000-00007     Document Type: Article

References (31)

1. Bierman PJ, Vose JM, Langnas AN, et al. Hodgkin's disease following solid organ transplantation. Ann Oncol. 1996;7:265-270.
2. Brauninger A, Hansmann ML, Strickler JG. Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999;340:1239-1247.
3. Cerilli J, Rynasiewicz JJ, Lemos LB, et al. Hodgkin's disease in human renal transplantation. Am J Surg Pathol. 1977;133:182-184.
4. Chang KL, Chen YY, Shibata D, et al. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol. 1992;1:246-255.
5. Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed Sternberg-like cells in posttransplantation lymphoproliferative disorders. Hum Pathol. 1997;28:493-498.
6. Dharnidharka VR, Douglas VK, Hunger SP, et al. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient. Pediatr Transplant. 2004;8:87-90.
7. Doyle TJ, Venkatachalam KK, Maeda K, et al. Hodgkin's disease in renal transplant recipients. Cancer. 1983;51:245-247.
8. Garnier JL, Lebranchu Y, Dantal J, et al. Hodgkin's disease after transplantation. Transplantation. 1996;61:71-76.
9. Goyal RK, McEvoy L, Wilson DB. Hodgkin's disease after renal transplantation: I. Childhood. J Pediatr Hematol Oncol. 1996;18:392-395.
10. Greiner TC, Raffeld M, Lutz C, et al. Analysis of T cell receptor-g gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products: correlation with tumor-specific sequences. Am J Pathol. 1995;146:46-55.
11. Gulley LG, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMP-1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002;117:259-267.
12. Harris NL, Swerdlow SH, Frizzera G, et al. Post-transplant lymphoproliferative disorders. In: Jaffe E, Harris N, Stein H, et al, eds. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2001, 264-269.
13. Hayashi RJ, Kraus MD, Patel AL, et al. Post-transplant lymphoproliferative disease in children: correlation of histology to clinical behaviour. J Pediatr Hematol Oncol. 2001;23:14-18.
14. Huang Q, Chang KL, Gaal KK, et al. KSHV/HHV8-associated lymphoma simulating anaplastic large cell lymphoma. Am J Surg Pathol. 2004;28:693-697.
15. Kanzler H, Kuppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184:1495-1505.
16. Midthum D, McDougall J, Peters S, et al. Medical management and complications in the lung transplant recipient. Mayo Clin Proc. 1997;72:175-184.
17. Nalesnik M, Jaffe R, Starzl TE, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporin A-prednisone immunosuppression. Am J Pathol. 1988;133:173-192.
18. Nalesnik M, Randhawa P, Demetris AJ, et al. Lymphoma resembling Hodgkin's disease after posttransplant lymphoproliferative disorder in a liver transplant recipient. Cancer. 1993;72:2568-2573.
19. Nalesnik MA. Post transplantation lymphoproliferative disorders (PTLD): current perspectives. Semin Thorac Cardiovasc Surg. 1996;8:139-148.
20. Oldhafer KJ, Bunzendahl H, Frei U, et al. Primary Hodgkin's lymphoma: an unusual cause of graft dysfunction after kidney transplantation. Am J Med. 1989;87:218-220.
21. Penn I. De novo malignancies in pediatric organ transplant recipients. Pediatr Transplant. 1998;2:56-63.
22. Pham P-TT, Wilkinson AH, Gritsch HA, et al. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with post-transplant lymphoproliferative disease. Transplant Proc. 2002;34:1178-1181.
23. Ranganathan S, Webber S, Ahuja S, et al. Hodgkin-like post-transplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma? Pediatr Dev Pathol. 2004;7:348-360.
24. Rowlings PA, Curtis RE, Passweg JR, et al. Increased incidence of Hodskin's disease after allogeneic bone marrow transplantation. J Clin Oncol. 1999;17:3122-3127.
25. Segal GH, Jorgensen T, Masih AS, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol. 1994;25:1269-1275.
26. Segal GH, Jorgensen T, Scott M, et al. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas. Hum Pathol. 1994;25:1276-1282.
27. Smets F, Vajro P, Cornu G, et al. indications and results of chemotherapy in children with post-transplant lymphoproliferative disease after liver transplantation. Transplantation. 2000;69:982-985.
28. Sterling WA, Wu LYF, Dowling EA. Hodgkin's disease in a renal transplant recipient. Transplantation. 1974;17:315-317.
29. Timms JM, Bell A, Flavell JR, et al. Target cells of Epstein-Barr virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodskin's lymphoma. Lancet. 2003;361:217-223.
30. Verschuuren EAM, Stevens SJC, van Inhofe GW, et al. Treatment of post-transplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation. 2002;73:100-104.
31. Younes SI, McDiarmid SV, Martin MG, et al. The effect of immunosuppression on post-transplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation. 2000;70:94-99.